FDA Inspection 1302098 — Omnia Biologix, LLC
The FDA completed an inspection of Omnia Biologix, LLC on February 4, 2026 in Morgantown, WV. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 4, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Morgantown, WV (United States)